^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Germ Cell Tumors
    Drug:gemcitabine (DNA synthesis inhibitor) +
    paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Malignant Germ cell tumors…Recurrence therapy…Other recommended Regimens…Paclitaxel/gemcitabine
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Third-line Chemotherapy Regimens for Metastatic Germ Cell tumors…High-Dose Chemotherapy previously Received…Preferred Regimens…Gemcitabine/Paclitaxel…
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Third-line Chemotherapy Regimens for Metastatic Germ Cell tumors…High-Dose Chemotherapy NOT previously Received…Other Recommended Regimens…Gemcitabine/Paclitaxel…